SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 4:15 PM ETAbout this dataData status
$27.63▼-0.84 (-2.97%)
After Hours:$27.63+0.00 (+0.00%)· 4:15 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.6 · elevated volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

Stock-Based Compensation

$8.50M

TTM · Period ending: · USD

PBLS logo

PBLS Stock-Based Compensation

Latest reported$8.50M
PBLS Stock-Based Comp ($4.31M → $8.50M)
High-resolution chart · PNG

What is stock-based compensation?

Non-cash compensation expense paid in equity.

PBLS stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Parabilis Medicines, Inc. Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
3,317,000
4,310,000

Frequently asked questions: PBLS stock-based compensation

What is Parabilis Medicines, Inc. (PBLS)'s current stock-based compensation?

Parabilis Medicines, Inc. (PBLS)'s latest reported stock-based compensation (TTM) is $8.50M as of Sep 30, 2026. Non-cash compensation expense paid in equity.

How much historical stock-based compensation data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s stock-based compensation, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's stock-based compensation to peers or set an alert?

You can open PBLS's stock-based compensation in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.